This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Id4pharma, LLC, Teijin Limited. Active years: 2007-2023.
Location History:
- Indianapolis, IN (US) (2017)
- Pittsburgh, PA (US) (2007 - 2023)
Company Filing History:
Years Active: 2007-2023
Title: An Insight into the Innovations of Inventor Noriyoshi Kurihara
Introduction
Noriyoshi Kurihara, an accomplished inventor based in Pittsburgh, PA, has made significant contributions to the field of medical science through his groundbreaking patents. With a total of three patents to his name, Kurihara is particularly known for his innovative approaches to treating diseases related to the p62 protein.
Latest Patents
Among his recent inventions, Kurihara's most notable patents include the p62-ZZ chemical inhibitor. This innovative method aims to treat p62-mediated diseases, such as multiple myeloma, by administering a therapeutically effective amount of at least one p62-ZZ inhibitor compound. The focus on p62-mediated diseases highlights his commitment to advancing therapeutic options in oncology.
Career Highlights
Throughout his career, Kurihara has been affiliated with various esteemed organizations, prominently including Id4pharma, LLC and Teijin Limited. His work at these companies has paved the way for compelling advancements in pharmaceutical research and treatment methodologies.
Collaborations
In his pursuit of innovation, Kurihara has collaborated with prominent figures in the scientific community, such as Xiang-Qun Xie and Garson David Roodman. These collaborations have undoubtedly enriched his research and contributed to the development of his patented technologies.
Conclusion
Noriyoshi Kurihara exemplifies the spirit of innovation in the medical field. His recent work with p62-ZZ chemical inhibitors represents a significant step forward in the treatment of complex diseases. As he continues to push the boundaries of medical research, his contributions remind us of the critical role inventors play in improving healthcare and saving lives.